Pushing the accelerator – speeding up drug research with accelerator mass spectrometry
Authors:
- R.C GarnerRGR.C Garner
- D LeongDLD Leong
- 1 October 2000
- journal article
- Published by Elsevier in Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms
- Vol. 172 (1-4) , 892-898
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Accelerator mass spectrometry and its applicationsReports on Progress in Physics, 1999
- Intrinsic Erythrocyte Labeling and Attomole Pharmacokinetic Tracing of14C-Labeled Folic Acid with Accelerator Mass SpectrometryAnalytical Biochemistry, 1999
- Comparison of DNA-adduct and tissue-available dose levels of MeIQx in human and rodent colon following administration of a very low doseInternational Journal of Cancer, 1999
- Accelerator mass spectrometry for assaying irreversible covalent modification of an enzyme by acetoacetic esterInternational Journal of Mass Spectrometry, 1998
- Distribution and metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine (PhIP) in female rats and their pups at dietary dosesCarcinogenesis, 1998
- Accelerator Mass Spectrometry as a Bioanalytical Tool for Nutritional Research1998
- A preliminary evaluation of accelerator mass spectrometry in the biomedical fieldJournal of Pharmaceutical and Biomedical Analysis, 1997
- Histone Adduction with Nicotine: A Bio-Ams StudyRadiocarbon, 1997
- Accelerator mass spectrometry in biomedical researchNuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms, 1994
- Accelerator mass spectrometry in biomedical dosimetry: relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA.Proceedings of the National Academy of Sciences, 1990